1312 related articles for article (PubMed ID: 17701884)
1. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
2. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
[TBL] [Abstract][Full Text] [Related]
3. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
Chanukvadze D; Kristesashvili J
Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
[TBL] [Abstract][Full Text] [Related]
6. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
7. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
8. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome.
Yasmin E; Balen AH; Barth JH
Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):173-7. PubMed ID: 23102586
[TBL] [Abstract][Full Text] [Related]
9. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
[TBL] [Abstract][Full Text] [Related]
10. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
12. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
Nadaraja RND; Sthaneshwar P; Razali N
Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
[TBL] [Abstract][Full Text] [Related]
13. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
14. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
Maitra A; Pingle RR; Menon PS; Naik V; Gokral JS; Meherji PK
Int J Fertil Womens Med; 2001; 46(5):271-7. PubMed ID: 11720200
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]